(Q39660126)

13 September 2017

1 reference

title

Methodology and safety considerations in the production of an intravenous immunoglobulin preparation (English)

1 reference

13 September 2017

Friedli HR

1

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

13 September 2017

1 reference

13 September 2017

volume

7

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

S36-40

1 reference

A prospective study of posttransfusion hepatitis. The role of Australia Antigen

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

Preparation and properties of a therapeutic factor IX concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

Prevention of Rh-immunization. Modified production of IgG anti-Rh for intravenous application by ion exchange chromatography (IEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

Transmission of hepatitis B by immune serum globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

Anticomplementary activity of human immunoglobulin G. I. Mechanism of the artifactual increase in anticomplementary activity of IgG during the assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

Distribution of IgG Subclasses in Commercial and Some Experimental γ-Globulin Preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03512.X

10.1002/J.1875-9114.1987.TB03512.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference